Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Citiolone is a small molecule drug used primarily in liver therapy as a hepatoprotectant and antioxidant. It is a derivative of the amino acid cysteine and acts as a hydroxyl free radical scavenger, providing protection against oxidative stress. Its mechanism involves increasing glutathione levels and accelerating superoxide dismutase (SOD), thereby reducing cellular damage from reactive oxygen species. Citiolone has also been studied for its neuroprotective effects in models of neurodegenerative diseases such as Parkinson’s disease and Alzheimer’s disease, where it inhibits oxidative stress-induced cytotoxicity. Additionally, it has been used as a mucolytic agent and for the treatment of chronic hepatitis[1][5][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on citiolone.